Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2878 (LINC02878)
- Target
- LINC02878
- Molecular classification
- Long non-coding RNA (lncRNA), Other
01
Overview
Long intergenic non-protein coding RNA 2878 (LINC02878), also known as BREA2, breast cancer estrogen-induced apoptosis 2, is a human long non-coding RNA (lncRNA) identified as promoting metastasis in breast cancer[4]. It is mechanistically linked to estrogen-induced apoptosis, particularly in endocrine-resistant breast cancer settings, and may have roles in cell stress responses and tumor progression. While not yet a clinically established therapeutic target, its involvement in crucial breast cancer biology pathways designates it as a potential target for future research and drug discovery, and it may serve as a candidate biomarker pending further validation. There is no evidence of spelling errors or incorrect naming; the entries found match authoritative gene and cancer research sources[4].
- Other names
- BREA2breast cancer estrogen-induced apoptosis 2
02
Mechanism of action
no specific drugs known to act directly on LINC02878; mechanistic action is inferred as regulation of apoptosis/metastasis, but no actionable inhibitor/agonist described
03
Biological functions
Regulation of apoptosis (specifically estrogen-induced apoptosis)Promotion of metastasisRegulation of stress responses (including unfolded protein response and oxidative stress, inferred from the pathway context of estrogen-induced apoptosis and lncRNA functions in cancer)Other
04
Disease associations
Cancer (breast cancer, especially endocrine-resistant breast cancer)Other (with main evidence in breast cancer context)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2878 (LINC02878).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2878 (LINC02878).